Enhanced Non-Invasive Optical Detection System with AI, IoT, Blockchain, and New Materials

The inventive concept integrates a non-invasive optical detection system with advanced technologies such as AI, IoT, blockchain, and new materials to create a more powerful system for detecting optical parameters in a scattering medium, offering enhanced accuracy, security, and personalized applications.

The original non-invasive optical detection system had limitations in real-time processing, data transmission, security, and accuracy. This inventive concept addresses these limitations by incorporating AI for real-time processing, IoT for efficient data transmission, blockchain for secure data management, and new materials for enhanced sensitivity.

The system comprises an artificial intelligence module for processing detected optical parameters in real-time, an IoT-enabled data transmission module for transmitting the processed optical parameters to a remote server for further analysis, a blockchain-enabled data authentication module for verifying the integrity of detected optical parameters, and new materials-based sensors for enhanced sensitivity and accuracy. The system can be used for detecting neural activity in the brain, creating personalized anatomical models, and detecting optical parameters in a scattering medium.

The inventive concept's novelty lies in the synergistic combination of a non-invasive optical detection system with AI, IoT, blockchain, and new materials, which provides a more powerful and secure system for detecting optical parameters. The inventive step is the integration of these distinct technologies to create a system that offers enhanced accuracy, security, and personalized applications.

Alternative embodiments may include using different AI algorithms, IoT protocols, blockchain platforms, or new materials. Variations may include integrating the system with other technologies such as robotics, computer vision, or machine learning.

The inventive concept has potential commercial applications in medical diagnostics, neuromodulation therapies, neuroengineering, brain-computer interfacing, and personalized medicine. The target industries include healthcare, medical devices, and technology.